G protein-coupled receptor 120 (GPR) is implicated in regulating CD4+ T cell production of IL-10 in the gut to inhibit the development of colitis, which identifies GPR 120 as a potential therapeutic target [233]. The gene discussed is CD4; the disease is colitis.